wegovy novo nordisk - Search News

FDA announces end to Wegovy and Ozempic drug shortages

USA TODAY on MSN · 1d

Novo's Wegovy and Ozempic removed from US FDA shortage list, compounders on notice

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, a declaration that will curtail widespread sales of cheaper copies made by compounding pharmacies.

FDA announces end to Wegovy and Ozempic drug shortages, but it could mean higher prices

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is over.

NBC New York · 1d

Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

1don MSN

Why Novo Nordisk Stock Popped on Friday

Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...

5don MSN

Novo Nordisk reprimanded for allegedly failing to disclose payments

The manufacturer of the weight loss jab Wegovy has been reprimanded for allegedly failing to disclose or accurately report ...

2don MSN

Novo Nordisk alleges fraud after US$1.3 billion deal to buy hypertension drug from Singapore-based KBP Biosciences

Novo Nordisk is seeking up to US$830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...

6don MSN

2 Important Insights From Novo Nordisk's Earnings Call

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

2d

Hotdogs and motorways: The ripples created by Denmark's Ozempic and Wegovy boom

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Hosted on MSN5d

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

Shares of weight loss and diabetes medication maker Novo Nordisk (NYSE: NVO) have slumped precipitously over the past 52 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results